Wolfe Research analyst Mike Polark downgraded Edwards Lifesciences to Peer Perform from Outperform with a "fair value" range for the stock at $65-$85.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on EW: